Bill Maris, a managing partner at Google Ventures, has moved the firm's investments toward companies that focus on slowing aging, combating disease, and lengthening life, Bloomberg Business says. A number of these companies are aim to tackle those problems by collecting consumers' DNA — Maris helped form Calico and Google Ventures invested in 23andMe — but he dismisses concerns regarding genetic privacy, it adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.